Volume : 09, Issue : 12, December – 2022
Title:
90.TO DEVELOP A VALIDATED ANALYTICAL METHOD FOR THE SIMULTANEOUS ESTIMATION OF METFORMIN, GLICLAZIDE AND VOGLIBOSE BY RP-HPLC
Authors :
B.Nishanth, V.Kiran Kumar
Abstract :
Another technique was built up for concurrent estimation of Metformin and Gliclazide and Voglibose RP-HPLC strategy. Metformin and Gliclazide was unreservedly solvent in water and liquor. Voglibose was uninhibitedly solvent in liquor and sparingly dissolvable in water. Methanol and potassium dihydrogen ortho phosphate ( pH 3) was picked as the versatile stage. The run season of the HPLC strategy was 5 minutes. The strategy was approved for framework appropriateness, linearity, exactness, precision, explicitness, roughness vigor, LOD and LOQ. The framework appropriateness boundaries were inside breaking point, subsequently it was presumed that the framework was reasonable to play out the examine. The strategy shows linearity between the focus scope of 10-100 µg/ml. The % recuperation of Metformin, Gliclazide and Voglibose were seen as in the scope of 99.23 % – 98.11 %. As there was no impedance due to excipients and portable stage, the technique was seen as explicit. The technique was powerful and rough as seen from immaterial variety in the consequences of examination by changes in Flow rate and Mobile stage sythesis independently and investigation being performed by various investigators.
Keywords: Metformin, Gliclazide and Voglibose, RP‐HPLC, Simultaneous estimation.
Cite This Article:
Please cite this article in press B.Nishanth et al, To Develop A Validated Analytical Method For The Simultaneous Estimation Of Metformin, Gliclazide And Voglibose By RP-HPLC.., Indo Am. J. P. Sci, 2022; 09(12).
Number of Downloads : 10
References:
:
1. Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F: Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond). 2012 Mar;122(6):253-70.
2. Rena G, Hardie DG, Pearson ER: The mechanisms of action of metformin. Diabetologia. 2017 Sep;60(9):1577-1585.
3. Rena G, Pearson ER, Sakamoto K: Molecular mechanism of action of metformin: old or new insights? Diabetologia. 2013 Sep;56(9):1898-906.
4. Ballagi-Pordany G, Koszeghy A, Koltai MZ, Aranyi Z, Pogatsa G: Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds. Diabetes Res Clin Pract. 1990 Jan;8(2):109-14. (PubMed ID 2106423)
5. Scholar E. (2007). XPharm: The comprehensive Pharmacology Reference. Elsevier.
6. Aso Y, Yamamoto R, Suetsugu M, Matsumoto S, Wakabayashi S, Matsutomo R, Takebayashi K, Inukai T: Comparison of the effects of pioglitazone and voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with Type 2 diabetes. Diabet Med. 2007 Sep;24(9):962-8. Epub 2007 May 17. [Article]
7. Kurebayashi S, Watada H, Tanaka Y, Kawasumi M, Kawamori R, Hirose T: Efficacy and adverse effects of nateglinide in early type 2 diabetes. Comparison with voglibose in a cross-over study. Endocr J. 2006 Apr;53(2):213-7. [Article]
8. Chhetri HP, Thapa P, Van Schepdael A. Simple HPLC-UV method for the quantification of metformin in human plasma with one step protein precipitation. Saudi Pharmaceut J. 2014;22:483–7. [PMC free article] [PubMed] [Google Scholar]
9. Kar M, Choudhury M. HPLC method for estimation of metformin hydrochloride in formulated microspheres and tablet dosage form. Indian J Pharmaceut Sci. 2009;71:318–20. [PMC free article] [PubMed] [Google Scholar]
10. Talar R, Arshosaz J, Mostafavi A, Nokhodchi A. Development and validation of a novel rp-hplc method for pharmacokinetic studies of gliclazide in rat. FARMACIA. 2011;59:388–95. [Google Scholar]
11. Ghai D, Ganesh GL. HPLC method for determination of gliclazide in human serum. Asian J Chem. 2009;21:4258–64. [Google Scholar]
12. Neelima K, Prasad YR. Analytical method development and validation of metformin, voglibose, glimepiride in bulk and combined tablet dosage form by gradient rp-hplc. Pharmaceut Meth. 2014;5:27–33. [Google Scholar]
13. Lakshmi K, Rajesh T, Sharma S. Simultaneous determination of metformin and pioglitazone by reversed phase HPLC in pharmaceutical dosage forms. Int J Pharm Pharmaceut Sci. 2009;1:162–6. [Google Scholar]
14. Shirode A, Maduskar P, Deodhar M, Kadam V. Rp-HPLC and HPTLC methods for simultaneous estimation of metformin hydrochloride and vildagliptin from bulk and marketed formulation: development and validation. Br J Pharmaceut Res. 2014;4:2370–86. [Google Scholar]
15. Soni LK, Narsinghani T, Jain M. Development and validation of RP-HPLC method for simultaneous estimation of metformin hydrochloride and repaglinide in tablet dosage form. J Liq Chromatogr Relat Technol. 2012;35:385–92. [Google Scholar]
16. Al Mahmud MA, Bhadra S, Haque A, Al Mamun ME, Haider SS. Development and validation of HPLC method for simultaneous determination of Gliclazide and Enalapril maleate in tablet dosage form. J Pharmaceut Sci. 2015;13:51–6. [Google Scholar]
17. Rathinavel G, Uma Nath U, Valarmathy J, Samueljoshua L, Thanuja CS, Ganesh M, et al. RP-HPLC method for the simultaneous estimation of rosiglitazone and gliclazide in tablets. J Chem. 2009;6:1188–92. [Google Scholar]
18. Havele S, Dhaneshwar S. Development and validation of a HPLC method for the determination of metformin hydrochloride, gliclazide and piogliglitazone hydrochloride in multicomponent formulation. Webmedcentral. 2010;1:WMC001078. [Google Scholar]
19. Mansoory NM, Jain A. Simultaneous estimation of metformin hydrochloride, pioglitazone hydrochloride and gliclazide by validated rp-hplc method in solid dosage form. Int J Pharm Pharmaceut Sci. 2012;4:72–6. [Google Scholar]
20. Ranetti M-C, Ionescu M, Hinescu L, Ionica E, Anuta V, Ranetti AE, et al. Validation of a HPLC method for the simultaneous analysis of metformin and gliclazide in human plasma. FARMACIA. 2009;57:728–35. [Google Scholar]